NYSE - Nasdaq Real Time Price USD

ResMed Inc. (RMD)

Time to buy RMD?

251.69

+3.11

+(1.25%)

At close: May 16 at 4:00:02 PM EDT

245.58

-6.11

(-2.43%)

After hours: May 16 at 6:49:11 PM EDT

Time to buy RMD?

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been named the Official Sleep Partner of the Qatar Airways British & Irish Lions Tour to Australia. The Tour brings rugby fans’ dreams to life over a six-week period. For the first time in 12 years, The Lions squad, alongside an estimated 40,000 fans, will battle it out with the Wallabies,

GlobeNewswire yesterday

RMD
+1.25%

RSMDF
Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ResMed (NYSE:RMD) and the best and worst performers in the patient monitoring industry.

StockStory 2 days ago

RMD
+1.25%

PODD

IRTC
3 Profitable Stocks to Consider Right Now

Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting themselves up for long-term success.

StockStory 11 days ago

CTAS

RMD
+1.25%
Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

Readers hoping to buy ResMed Inc. ( NYSE:RMD ) for its dividend will need to make their move shortly, as the stock is...

Simply Wall St. 13 days ago

RMD
+1.25%

RSMDF
This ResMed Insider Reduced Their Stake By 72%

From what we can see, insiders were net sellers in ResMed Inc.'s ( NYSE:RMD ) during the past 12 months. That is...

Simply Wall St. 14 days ago

RMD
+1.25%

RSMDF
Resmed acquires independent diagnostic testing facility VirtuOx

The deal is set to enhance Resmed's ability to collaborate with healthcare providers to improve the diagnostic process.

Medical Device Network 14 days ago

RMD
+1.25%
Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience hired an executive to support its BCI commercialization plans.

MedTech Dive 14 days ago

RMD
+1.25%
Why ResMed (RMD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 15 days ago

RMD
+1.25%
Resmed Acquires VirtuOx

Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providersSAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s co

GlobeNewswire 15 days ago

RMD
+1.25%

RSMDF
Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

We recently published a list of Jim Cramer Says The Day “Everything’s A Lot More Expensive” Is Coming & Discusses These 10 Stocks. In this article, we are going to take a look at where Resmed Inc (NYSE:RMD) stands against other stocks that Jim Cramer recently discussed. In his appearance on CNBC’s Squawk on the […]

Insider Monkey 16 days ago

RMD
+1.25%
iRhythm Earnings: What To Look For From IRTC

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting results tomorrow afternoon. Here’s what investors should know.

StockStory 16 days ago

IRTC

RMD
+1.25%
RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with analysts’ consensus estimates.

StockStory 20 days ago

RMD
+1.25%
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025.

Zacks 21 days ago

MMSI

RMD
+1.25%

EHC
ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 21 days ago

RMD
+1.25%
ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

Recently, ResMed (NYSE:RMD) reported solid financial performance for the quarter ending March 31, 2025, with sales increasing to $1,292 million and net income reaching $365 million year-over-year. The company declared a quarterly cash dividend of $0.53 per share. Despite a 1.39% share price increase over the last week, ResMed's movement was relatively subdued compared to broader market gains, with major indexes like the Nasdaq rising notably amid a tech rally. The positive earnings report and...

Simply Wall St. 22 days ago

RMD
+1.25%

RSMDF
Q3 2025 Resmed Inc Earnings Call

Q3 2025 Resmed Inc Earnings Call

Thomson Reuters StreetEvents 22 days ago

RMD
+1.25%
ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

RMD's stellar third-quarter fiscal 2025 results reflect the ongoing momentum and strong execution across all areas of its business.

Zacks 22 days ago

RMD
+1.25%
ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

ResMed Inc (RMD) reports an 8% revenue increase and plans to boost share buybacks, while navigating global trade challenges and expanding its digital health ecosystem.

GuruFocus.com 22 days ago

RMD
+1.25%
Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

Although the revenue and EPS for ResMed (RMD) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks 23 days ago

RMD
+1.25%
ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

ResMed (RMD) delivered earnings and revenue surprises of 0.42% and 0.53%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 23 days ago

RMD
+1.25%

Performance Overview

Return	RMD	S&P 500 (^GSPC)
YTD	+10.54%	+1.30%
1-Year	+15.45%	+12.48%
3-Year	+31.36%	+48.66%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

ResMed Inc. (RMD)

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

3 Profitable Stocks to Consider Right Now

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

This ResMed Insider Reduced Their Stake By 72%

Resmed acquires independent diagnostic testing facility VirtuOx

Intuitive wins new FDA nod for single port robot; Resmed buys diagnostic facility

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Resmed Acquires VirtuOx

Resmed Inc (RMD): Jim Cramer Says “Remarkable Stock” — Did GLP-1 Drugs Just Hand It a Lifeline?

iRhythm Earnings: What To Look For From IRTC

RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter

MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

ResMed (NYSE:RMD) Reports Strong Q3 Earnings Growth and Declares US$0.53 Dividend

Q3 2025 Resmed Inc Earnings Call

ResMed Q3 Earnings and Revenues Beat, Stock Up in After-Market

ResMed Inc (RMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Here's What Key Metrics Tell Us About ResMed (RMD) Q3 Earnings

ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates

Performance Overview